Audrey Davis

1.3k total citations
31 papers, 634 citations indexed

About

Audrey Davis is a scholar working on Pharmacology, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Audrey Davis has authored 31 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 12 papers in Molecular Biology and 11 papers in Computational Theory and Mathematics. Recurrent topics in Audrey Davis's work include Cholinesterase and Neurodegenerative Diseases (13 papers), Computational Drug Discovery Methods (11 papers) and Receptor Mechanisms and Signaling (6 papers). Audrey Davis is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (13 papers), Computational Drug Discovery Methods (11 papers) and Receptor Mechanisms and Signaling (6 papers). Audrey Davis collaborates with scholars based in France, Italy and Hungary. Audrey Davis's co-authors include D. R. Shackleton Bailey, Patrick Dallemagne, Christophe Rochais, Cédric Lecoutey, Michel Boulouard, Jana Sopková‐de Oliveira Santos, Marc Since, Thomas Fréret, Sylvie Claeysen and Sophie Corvaisier and has published in prestigious journals such as Journal of Hazardous Materials, Scientific Reports and British Journal of Pharmacology.

In The Last Decade

Audrey Davis

30 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Audrey Davis France	17	230	181	180	143	101	31	634
Peter Bozner United States	13	342 1.5×	78 0.4×	162 0.9×	67 0.5×	42 0.4×	18	958
Clara Albani Argentina	14	127 0.6×	51 0.3×	180 1.0×	27 0.2×	58 0.6×	30	556
Gregory E. Garcia United States	14	139 0.6×	55 0.3×	286 1.6×	107 0.7×	105 1.0×	25	679
Robson Xavier Faria Brazil	20	317 1.4×	75 0.4×	50 0.3×	17 0.1×	260 2.6×	82	1.2k
Danish Mahmood Saudi Arabia	16	180 0.8×	56 0.3×	46 0.3×	29 0.2×	54 0.5×	44	613
Omar Jbilo France	14	339 1.5×	230 1.3×	663 3.7×	88 0.6×	42 0.4×	21	1.1k
Claudia Suenderhauf Switzerland	13	109 0.5×	31 0.2×	59 0.3×	77 0.5×	19 0.2×	19	473
Haim Meshulam Israel	16	284 1.2×	113 0.6×	159 0.9×	33 0.2×	99 1.0×	25	608
Lan‐Xue Zhao China	14	271 1.2×	82 0.5×	133 0.7×	40 0.3×	53 0.5×	26	721
James B. Fischer United States	18	552 2.4×	297 1.6×	182 1.0×	27 0.2×	267 2.6×	40	945

Countries citing papers authored by Audrey Davis

Since Specialization

Citations

This map shows the geographic impact of Audrey Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Audrey Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Audrey Davis more than expected).

Fields of papers citing papers by Audrey Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Audrey Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Audrey Davis. The network helps show where Audrey Davis may publish in the future.

Co-authorship network of co-authors of Audrey Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Audrey Davis. A scholar is included among the top collaborators of Audrey Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Audrey Davis. Audrey Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rochais, Christophe, Cédric Lecoutey, Audrey Davis, et al.. (2024). Synthesis, in vitro and in vivo biological evaluation of novel dual compounds targeting both acetylcholinesterase and serotonergic 5-HT4 receptors with potential interest in the treatment of Alzheimer's disease. European Journal of Medicinal Chemistry. 280. 116975–116975.

Davis, Audrey, María Valcárcel, Isbaal Ramos, et al.. (2024). Development of Pleiotropic TrkB and 5-HT4 Receptor Ligands as Neuroprotective Agents. Molecules. 29(2). 515–515. 3 indexed citations

Malek, R.S., Audrey Davis, Maciej Maj, et al.. (2022). Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca2+ Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation. Molecules. 28(1). 71–71. 9 indexed citations

Verdié, Pascal, Audrey Davis, Sophie Corvaisier, et al.. (2021). Active Targeted Nanoemulsions for Repurposing of Tegaserod in Alzheimer’s Disease Treatment. Pharmaceutics. 13(10). 1626–1626. 9 indexed citations

Lecoutey, Cédric, Rémi Legay, Audrey Davis, et al.. (2021). Development of Novel Potential Pleiotropic Compounds of Interest in Alzheimer’s Disease Treatment through Rigidification Strategy. Molecules. 26(9). 2536–2536. 5 indexed citations

Groo, Anne‐Claire, Céline Picard, Audrey Davis, et al.. (2020). Pharmacotechnical Development of a Nasal Drug Delivery Composite Nanosystem Intended for Alzheimer’s Disease Treatment. Pharmaceutics. 12(3). 251–251. 60 indexed citations

Lecoutey, Cédric, Rémi Legay, Audrey Davis, et al.. (2020). First Synthesis of Racemic Trans Propargylamino-Donepezil, a Pleiotrope Agent Able to Both Inhibit AChE and MAO-B, with Potential Interest against Alzheimer’s Disease. Molecules. 26(1). 80–80. 16 indexed citations

Lecoutey, Cédric, Audrey Davis, Marc Since, et al.. (2020). Pleiotropic prodrugs: Design of a dual butyrylcholinesterase inhibitor and 5-HT6 receptor antagonist with therapeutic interest in Alzheimer’s disease. European Journal of Medicinal Chemistry. 210. 113059–113059. 25 indexed citations

Tournier, Benjamin B., Audrey Davis, Emmanuelle Dubost⧫, et al.. (2020). Design of iodinated radioligands for SPECT imaging of central human 5-HT4R using a ligand lipophilicity efficiency approach. Bioorganic Chemistry. 96. 103582–103582. 2 indexed citations

10.

Davis, Audrey, Cédric Lecoutey, Rémi Legay, et al.. (2020). Rational design of novel benzisoxazole derivatives with acetylcholinesterase inhibitory and serotoninergic 5-HT4 receptors activities for the treatment of Alzheimer’s disease. Scientific Reports. 10(1). 3014–3014. 29 indexed citations

11.

Lecoutey, Cédric, Audrey Davis, Marc Since, et al.. (2019). Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer’s Disease. Molecules. 24(15). 2786–2786. 20 indexed citations

12.

Lecoutey, Cédric, Marc Since, Audrey Davis, et al.. (2019). Novel multi target-directed ligands targeting 5-HT4 receptors with in cellulo antioxidant properties as promising leads in Alzheimer's disease. European Journal of Medicinal Chemistry. 182. 111596–111596. 12 indexed citations

13.

Yahiaoui, Samir, Cédric Lecoutey, Audrey Davis, et al.. (2019). A Novel in vivo Anti-amnesic Agent, Specially Designed to Express Both Acetylcholinesterase (AChE) Inhibitory, Serotonergic Subtype 4 Receptor (5-HT4R) Agonist and Serotonergic Subtype 6 Receptor (5-HT6R) Inverse Agonist Activities, With a Potential Interest Against Alzheimer’s Disease. Frontiers in Aging Neuroscience. 11. 148–148. 21 indexed citations

14.

Santoni, Gianluca, Delphine Karila, Cédric Lecoutey, et al.. (2018). Novel multitarget-directed ligands targeting acetylcholinesterase and σ1 receptors as lead compounds for treatment of Alzheimer's disease: Synthesis, evaluation, and structural characterization of their complexes with acetylcholinesterase. European Journal of Medicinal Chemistry. 162. 234–248. 39 indexed citations

15.

Tournier, Benjamin B., Thomas Cailly, Cédric Lecoutey, et al.. (2016). Synthesis and evaluation of novel serotonin 4 receptor radiotracers for single photon emission computed tomography. European Journal of Medicinal Chemistry. 116. 90–101. 8 indexed citations

16.

Yahiaoui, Samir, Céline Ballandonne, Audrey Davis, et al.. (2016). Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer’s disease. European Journal of Medicinal Chemistry. 121. 283–293. 34 indexed citations

17.

Marie, Nicolas, et al.. (2013). Remifentanil produces cross-desensitization and tolerance with morphine on the mu-opioid receptor. Neuropharmacology. 73. 368–379. 22 indexed citations

18.

Coulbault, Laurent, Audrey Davis, Nicolas Marie, et al.. (2011). ßarrestin1-biased agonism at human δ-opioid receptor by peptidic and alkaloid ligands. Cellular Signalling. 24(3). 699–707. 12 indexed citations

19.

Marie, Nicolas, et al.. (2008). Different kinases desensitize the human δ-opioid receptor (hDOP-R) in the neuroblastoma cell line SK-N-BE upon peptidic and alkaloid agonists. Cellular Signalling. 20(6). 1209–1220. 13 indexed citations

20.

Coulbault, Laurent, Michel Boulouard, Audrey Davis, et al.. (2007). In vitroandin vivopharmacological profile of UFP‐512, a novel selective δ‐opioid receptor agonist; correlations between desensitization and tolerance. British Journal of Pharmacology. 152(8). 1312–1324. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact